Matthew P Yates

Title: Matthew P. Yates: Innovator in Epidermal Growth Factor Research

Introduction

Matthew P. Yates is a notable inventor based in Dardenne Prairie, MO (US). He has made significant contributions to the field of biomedical research, particularly in the development of epidermal growth factor (EGF)-based reagents. His innovative work aims to address critical medical conditions, showcasing his dedication to advancing healthcare solutions.

Latest Patents

Matthew P. Yates holds a patent for "Fatty Acid Modified Human Epidermal Growth Factor." This patent describes new EGF-based reagents that have been modified through fatty acid conjugation. The disclosure also outlines methods for using these agents in the treatment of Short Bowel Syndrome (SBS). His work in this area represents a significant advancement in therapeutic options for patients suffering from this condition.

Career Highlights

Yates is affiliated with Saint Louis University, where he continues to engage in research and development. His role at the university allows him to collaborate with other experts in the field and contribute to groundbreaking studies. His commitment to innovation is evident in his research endeavors and the impact of his work on medical science.

Collaborations

Matthew P. Yates has worked alongside esteemed colleagues such as Marvin Jay Meyers and David Collier Wood. These collaborations have fostered an environment of shared knowledge and expertise, further enhancing the quality of research conducted in their field.

Conclusion

Matthew P. Yates is a distinguished inventor whose work in epidermal growth factor research has the potential to transform treatment options for patients with Short Bowel Syndrome. His contributions to the field exemplify the importance of innovation in healthcare.